Here’s what you need to know.
1. The company released its earnings on Aug. 3. It had a $0.27 earnings per share for the quarter, which was significantly lower than Thomson Reuters’ $0.35 EPS estimate.
2. Four research analysts gave Entellus a “buy” rating.
3. During the quarter, Entellus earned $18.73 million.
4. Revenue was also up 23.3 percent on a year-over-year basis.
More orthopedic and spinal device news:
Alphatec CFO resigns; company cuts workforce by 20% & more company updates — 5 key points
Capital Regional Orthopaedic performs 1st NUsurface procedure in NY: 4 notes
Medicare spends $1.5B on defective devices — 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
